Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
OPERATING EXPENSES
Research and development expenses	$ 41,746	$ 14,575	$ 64,943	$ 30,177
General and administrative expenses	236,479	358,181	739,884	1,175,920
Total operating expenses	278,225	372,756	804,827	1,206,097
LOSS FROM OPERATIONS	(278,225)	(372,756)	(804,827)	(1,206,097)
LOSS, BEFORE TAX	(278,225)	(372,756)	(804,827)	(1,206,097)
Income tax benefit (expense)
NET LOSS	$ (278,225)	$ (372,756)	$ (804,827)	$ (1,206,097)
Net loss per share attributable to common stockholders, basic	$ (0.02)	$ (0.03)	$ (0.07)	$ (0.11)
Net loss per share attributable to common stockholders, diluted	$ (0.02)	$ (0.03)	$ (0.07)	$ (0.11)
Weighted average common shares outstanding used in computing net loss per share attributable to common stockholders, basic	11,346,535	11,346,535	11,346,535	11,346,535
Weighted average common shares outstanding used in computing net loss per share attributable to common stockholders, diluted	11,346,535	11,346,535	11,346,535	11,346,535